Lexeo Therapeutics, Inc. (LXEO): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$654.0K
Year ended 2022-12-31
Period endedRevenueChange YoYSource filing
2022-12-31$654.0Kn/a2024-03-11, From 2022-01-01